BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31982215)

  • 1. Reaching consensus on a home infusion central line-associated bloodstream infection surveillance definition via a modified Delphi approach.
    Keller S; Salinas A; Williams D; McGoldrick M; Gorski L; Alexander M; Norris A; Charron J; Stienecker RS; Passaretti C; Maragakis L; Cosgrove SE
    Am J Infect Control; 2020 Sep; 48(9):993-1000. PubMed ID: 31982215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
    Keller SC; Hannum SM; Weems K; Oladapo-Shittu O; Salinas AB; Marsteller JA; Gurses AP; Klein EY; Shpitser I; Crnich CJ; Bhanot N; Rock C; Cosgrove SE;
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1748-1759. PubMed ID: 37078467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainable neonatal CLABSI surveillance: consensus towards new criteria in the Netherlands.
    Heijting IE; Antonius TAJ; Tostmann A; de Boode WP; Hogeveen M; Hopman J;
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):31. PubMed ID: 33546759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A task analysis of central line-associated bloodstream infection (CLABSI) surveillance in home infusion therapy.
    Hannum SM; Oladapo-Shittu O; Salinas AB; Weems K; Marsteller J; Gurses AP; Cosgrove SE; Keller SC
    Am J Infect Control; 2022 May; 50(5):555-562. PubMed ID: 35341660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance and attribution of ambulatory central line-associated bloodstream infections in a pediatric healthcare system.
    Hei H; Plaras M; Paul E; Satchell L; Bezpalko O; Handy L
    Am J Infect Control; 2023 Feb; 51(2):220-224. PubMed ID: 35718060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
    Jayaweera JAAS; Sivakumar D
    BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.
    Rinke ML; Bundy DG; Milstone AM; Deuber K; Chen AR; Colantuoni E; Miller MR
    Jt Comm J Qual Patient Saf; 2013 Aug; 39(8):361-70. PubMed ID: 23991509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Oladapo-Shittu O; Cosgrove SE; Rock C; Hsu YJ; Klein E; Harris AD; Mejia-Chew C; Saunders H; Ching PR; Gadala A; Mayoryk S; Pineles L; Maragakis L; Salinas A; Helsel T; Keller SC
    Clin Infect Dis; 2024 Jun; 78(6):1632-1639. PubMed ID: 38483930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the case numbers of catheter-related bloodstream infection overestimated by the central line-associated bloodstream infection surveillance definition.
    Chen XX; Lo YC; Su LH; Chang CL
    J Microbiol Immunol Infect; 2015 Dec; 48(6):625-31. PubMed ID: 24856425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic scoping review of automated systems for the surveillance of healthcare-associated bloodstream infections related to intravascular catheters.
    Lotfinejad N; Januel JM; Tschudin-Sutter S; Schreiber PW; Grandbastien B; Damonti L; Lo Priore E; Scherrer A; Harbarth S; Catho G; Buetti N;
    Antimicrob Resist Infect Control; 2024 Feb; 13(1):25. PubMed ID: 38419046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
    Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
    JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from a hospital-wide review of blood stream infections for paediatric central line-associated blood stream infection prevention.
    Campbell AJ; Blyth CC; Hewison CJ; Chen YP; Gough L; Goff Z; Bowen AC
    J Paediatr Child Health; 2019 Jun; 55(6):690-694. PubMed ID: 30315622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Model to Predict Central-Line-Associated Bloodstream Infection Among Patients With Peripherally Inserted Central Catheters: The MPC Score.
    Herc E; Patel P; Washer LL; Conlon A; Flanders SA; Chopra V
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1155-1166. PubMed ID: 28807074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central line-associated bloodstream infection in neonatal intensive care units.
    Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.
    Chaftari AM; Jordan M; Hachem R; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Deshmukh P; Raad I
    Am J Infect Control; 2016 Aug; 44(8):931-4. PubMed ID: 27112370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.